DOCSLIB.ORG

Manual Provocation Test for Intermittent Involutional Entropion

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Manual Provocation Test for Intermittent Involutional Entropion CLINICAL SCIENCE Manual Provocation Test for Intermittent Involutional Entropion Rahul S. Tonk, MD, MBA, and Dale R. Meyer, MD, FACS ntropion is an eyelid malposition characterized by inward Purpose: To describe the manual provocation test (MPT), a novel Erotation of the eyelid margin and eyelashes toward the test for intermittent involutional entropion of the lower eyelid. ocular surface. It can be associated with various degrees of fl Methods: Retrospective review of patients with intermittent visual morbidity, including in ammation of the conjunctiva, corneal abrasions, microbial keratitis, corneal vascularization, entropion who presented with ocular irritation and documented 1–3 inward eyelid rotation by them or their referring physicians, but and vision loss. Entropion can be divided into 4 main types who had no apparent entropion at the time of initial consultation. according to the cause: congenital, involutional, spastic, and Results of the MPT were recorded for this group, and then cicatricial. Involutional entropion is the most common type seen evaluated prospectively in an age-matched comparison group of in general ophthalmic practice, and has been reported to occur in approximately 2% of the elderly population. Its prevalence is patients presenting for blepharoplasty who had no history of 2,4 entropion. The essential steps of the MPT are as follows. Step 1: projected to increase as the population ages. The pathophys- the lower eyelid skin is grasped below the inferior border of the iology of lower eyelid involutional entropion has been well tarsal plate. Step 2: the lid is drawn anteriorly as with the eyelid described, and generally includes horizontal eyelid laxity, distraction test. Step 3: the patient is directed to forcefully close the retractor dehiscence, and overriding of the preseptal orbicularis oculi onto the pretarsal orbicularis. Surgical treatment is often eyelids. Step 4: the eyelid is released and the result is observed for 3,5–9 manifest entropion. required in symptomatic patients. Entropion can be manifest at all times or it can be Results: Thirteen eyelids in 12 patients with intermittent involu- intermittent, occurring at a variable frequency with intervals tional lower eyelid entropion were included in this study. Average of relatively normal (ie, not overtly malpositioned) eyelid patient age was 77.3 years (69.5 SD). The MPT elicited entropion in position. In cases where a patient’s history is not classic, this all 13 eyelids. Of the 12 patients, 9 elected to pursue surgery and, of can result in ocular surface irritation of uncertain etiology.10 these patients, all eyelids were successfully treated with subsequent We have developed a simple test to aid in the evaluation of improvement of symptoms. The MPT was thereafter negative in patients reported to have involutional entropion, but in whom these patients. None of the 20 patients in the blepharoplasty entropion is not manifest on examination. In this article, we comparison group (average age 71.6 years) demonstrated a positi- describe our experience with this test, which we refer to as the ve MPT. manual provocation test (MPT) for entropion, and compare it with known measures. Conclusions: The MPT can be a valuable and straightforward test in the clinical evaluation of patients with a history of intermittent entropion. METHODS Key Words: ocular surface, dry eye, entropion, intermittent A retrospective review was done for patients presenting entropion, ocular irritation with intermittent involutional lower eyelid entropion in the (Cornea 2016;35:510–512) practice of one of the authors (D.R.M.) between April 2013 and May 2014. Patients were included if they complained of ocular irritation and had entropion observed by their referring physician or by themselves at some point in the past, but no manifest entropion on initial consultation either at rest or Received for publication September 4, 2015; revision received November 13, upon squeezing their eyelids. Results of the test as described 2015; accepted December 12, 2015. Published online ahead of print herein were recorded along with data on patient age, gender, February 18, 2016. and surgical repair. From the Department of Ophthalmology, Lions Eye Institute, Albany Medical Results of the MPT were then prospectively evaluated College, Albany, NY. The authors have no funding or conflicts of interest to disclose. in a nonrandomized comparison group of 20 consecutive Supplemental digital content is available for this article. Direct URL citations patients presenting for blepharoplasty. This group was appear in the printed text and are provided in the HTML and PDF conveniently chosen to evaluate this test in a similar age versions of this article on the journal’s Web site (www.corneajrnl.com). group without a history or evidence of entropion. Statistical Reprints: Rahul S. Tonk, MD, MBA, Department of Ophthalmology, Lions Eye Institute, Albany Medical College, 1220 New Scotland Ave, Suite evaluation using t test was performed to compare the mean 302, Slingerlands, NY 12159 (e-mail: [email protected]). age of these 2 groups. This study was approved by the Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. Institutional Review Board of Albany Medical Center. 510 | www.corneajrnl.com Cornea Volume 35, Number 4, April 2016 Copyright Ó 2016 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited. Cornea Volume 35, Number 4, April 2016 Manual Provocation Test MPT Description these patients was thereafter negative. Of the 20 patients in The test essentially involves the 4 steps described the age-matched blepharoplasty comparison group, none had below and as shown in Fig. 1 (see Video, Supplemental a positive MPT. The average age of the blepharoplasty Digital Content 1, http://links.lww.com/ICO/A386, for group, 71.6 years (611.5 SD, range 56–98 years), was not a demonstration). significantly different from that of the intermittent entropion group (P =0.15). Step 1 The lower eyelid skin is grasped between the thumb and forefinger within the “preseptal zone” (inferior border of DISCUSSION the tarsal plate to the inferior orbital rim) (Fig. 1A). The evaluation of intermittent involutional entropion involves a thorough history and physical examination that Step 2 includes assessment of eyelid position, typically with some The eyelid is drawn anteriorly away from the globe as attempt to provoke or induce entropion if it is not overtly with the eyelid distraction test,3 and a general assessment of present, as well as evaluation of any coexistent ocular eyelid laxity can be made (Fig. 1B). surface disorder. Horizontal lower eyelid laxity, per se, can be detected by simple eyelid distraction and Step 3 snapback tests.3,11 The former is generally considered The patient is directed to forcefully close the eyelids suggestive of eyelid laxity if the lower eyelid can be pulled (Fig. 1C). more than 6 mm from the globe, and the latter if the eyelid is slow to return to its resting position after being Step 4 pulled inferiorly. The eyelid is released and the result is observed for A handful of measures have been previously described development of manifest entropion (Fig. 1D). to help “uncover” entropion in patients with a history of The test may be repeated, if desired, after returning the observed entropion who nevertheless present without overt eyelid to the noninverted position. in-turning of the eyelid margin at consultation, representing so-called intermittent entropion. Entropion may become manifest after the patient voluntarily and forcefully closes RESULTS (squeezes) the eyelids, which can elicit superior override of A total of 13 eyelids in 12 consecutive patients the preseptal onto the pretarsal orbicularis.1,3,10,12 For patients presenting with a history of intermittent involutional lower who cannot follow commands, Kashani et al12 have described eyelid entropion were evaluated using the MPT reported in instillation of topical ophthalmic anesthetic to produce ocular this study. Of these 12 patients, 5 (41.7%) were male and 7 irritation and subsequent orbicularis contraction, a technique (58.3%) were female. Average patient age was 77.3 years they refer to as the tetracaine provocation test. Faria-e-Sousa (69.5 SD) with a range of 57 to 90 years. The MPT et al10 describe another maneuver that they refer to as the test described above elicited entropion in all 13 eyelids. Of the of induced entropion (“TIE”). Essentially, the TIE involves 12 patients, 9 elected to pursue a previously described topically anesthetizing the eye, manually lifting/rolling lower surgery involving transconjunctival lower eyelid retractor eyelid skin over the tarsal edge, and spreading the resultant plication combined with horizontal tightening.8,9 All these inverted eyelid flat against the eyeball. The test is considered patients had resolution of their ocular discomfort after positive if the induced entropion remains stable for at surgery.TheMPTthathadbeenusedtoelicitentropionin least 3 minutes. FIGURE 1. The MPT for intermittent entropion. A, The patient has no apparent entropion on initial exami- nation. B, The lower eyelid is grasped within the “preseptal zone” and pulled anteriorly away from the globe. C, The patient forcefully squeezes the eyelids. D, After release, the patient demonstrates manifest lower eyelid entropion. Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. www.corneajrnl.com | 511 Copyright Ó 2016 Wolters Kluwer Health, Inc. Unauthorized reproduction of this article is prohibited. Tonk and Meyer Cornea Volume 35, Number 4, April 2016 In the present article, we describe what we term the REFERENCES manual provocation test, which, in this series, was able 1. Pereira MG, Rodrigues MA, Rodrigues SA. Eyelid entropion. Semin to elicit entropion in 13 eyelids of 12 patients with a history of Ophthalmol. 2010;25:52–58. 2. Boboridis KG, Bunce C. Interventions for involutional lower lid ocular irritation and intermittent entropion, but no manifest entropion. Cochrane Database Syst Rev. 2011;CD002221. entropion on examination either at rest or with eyelid 3. Skuta GL, Cantor LB, Cioffi GA, et al.
Load more

Recommended publications
  • Dana Pearl Tannenbaum, M
    DANA P. TANNENBAUM, M.D. A Center for VisionCare 2031 W. Alameda Avenue, Suite 300 Burbank, CA 91506 Tel (818) 762-0647 Fax (818) 762-0996 [email protected] EMPLOYMENT 2003 – current Physician A Center For VisionCare, North Hollywood, California. 2003 – 2012 Consultant Southern California College of Optometry, Los Angeles, California. 2003 – 2011 Clinical Instructor of Ophthalmology Jules Stein Eye Institute, University of California, Los Angeles, California. 2002 – 2003 Visiting Assistant Professor Jules Stein Eye Institute, University of California, Los Angeles, California. EDUCATION Medical 2001 – 2003 Glaucoma Fellowship Jules Stein Eye Institute, University of California, Los Angeles, California. 1998 – 2001 Ophthalmology Residency Training Program Shiley Eye Center, University of California, San Diego, California. 1997 – 1998 Internal Medicine Internship Hahnemann University Hospital, Philadelphia, Pennsylvania. 1993 – 1997 McGill University Faculty Of Medicine Montreal, Canada. Doctor of Medicine. Undergraduate 1992 – 1993 McGill University Faculty Of Science Montreal, Canada. Medical Preparatory Year. 1990 – 1992 Vanier College Montreal, Canada. Diploma of Health Sciences. LICENSURE AND CERTIFICATIONS 2002 – present Board Certification in Ophthalmology 1998 – present California Medical License 1997 – 1998 Pennsylvania Medical Training License PROFESSIONAL ORGANIZATIONS 2004 – present American Glaucoma Society 1998 – present California Academy of Ophthalmology 1998 – present American Academy of Ophthalmology 1998 – present American Society of Cataract and Refractive Surgery 1996 – present Association for Research in Vision and Ophthalmology EDITORIAL BOARDS 2003 – 2010 Reviewer, American Journal of Ophthalmology 2003 – 2010 Reviewer, Ophthalmology HONORS AND AWARDS 2012 - 2015 Compassionate Doctor Recognition Award 2012 - 2015 Patients Choice Award 2003 Glaucoma Merit Award Pharmacia Glaucoma Fellow Awards Program 2002 - 2003 Klara Spinks Fleming Fellowship Jules Stein Eye Institute, University of California, Los Angeles, California.
    [Show full text]
  • Myopia Genetics Report
    Special Issue IMI – Myopia Genetics Report Milly S. Tedja,1,2 Annechien E. G. Haarman,1,2 Magda A. Meester-Smoor,1,2 Jaakko Kaprio,3,4 David A. Mackey,5–7 Jeremy A. Guggenheim,8 Christopher J. Hammond,9 Virginie J. M. Verhoeven,1,2,10 and Caroline C. W. Klaver1,2,11; for the CREAM Consortium 1Department of Ophthalmology, Erasmus Medical Center, Rotterdam, the Netherlands 2Department of Epidemiology, Erasmus Medical Center, Rotterdam, the Netherlands 3Institute for Molecular Medicine, University of Helsinki, Helsinki, Finland 4Department of Public Health, University of Helsinki, Helsinki, Finland 5Centre for Eye Research Australia, Ophthalmology, Department of Surgery, University of Melbourne, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, Australia 6Department of Ophthalmology, Menzies Institute of Medical Research, University of Tasmania, Hobart, Tasmania, Australia 7Centre for Ophthalmology and Visual Science, Lions Eye Institute, University of Western Australia, Perth, Western Australia, Australia 8School of Optometry and Vision Sciences, Cardiff University, Cardiff, United Kingdom 9Section of Academic Ophthalmology, School of Life Course Sciences, King’s College London, London, United Kingdom 10Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, the Netherlands 11Department of Ophthalmology, Radboud University Medical Center, Nijmegen, the Netherlands Correspondence: Caroline C. W. The knowledge on the genetic background of refractive error and myopia has expanded Klaver, Erasmus Medical Center, dramatically in the past few years. This white paper aims to provide a concise summary of Room Na-2808, P.O. Box 2040, 3000 current genetic findings and defines the direction where development is needed. CA, Rotterdam, the Netherlands; [email protected]. We performed an extensive literature search and conducted informal discussions with key MST and AEGH contributed equally to stakeholders.
    [Show full text]
  • Curriculum Vitae
    CURRICULUM VITAE Jeffrey L. Olson, M.D. Associate Professor Vitreoretinal Disease and Surgery University of Colorado School of Medicine Department of Ophthalmology UCHealth Eye Center - Anschutz 1675 Aurora Court, Mailstop F731 Aurora, CO 80045 Appointments: 720-848-2020 PREDOCTORAL EDUCATION 1989 – 1993 Pre-medical: B.A., Sociology, University of Virginia, Charlottesville, VA 1995 – 1999 Medical: M.D., University of Colorado School of Medicine, Denver, CO POSTDOCTORAL TRAINING 1999 – 2000 Internship: Internal Medicine, Marshfield Clinic, University of Wisconsin School of Medicine and Public Health, Marshfield, WI 2000 – 2003 Residency: Ophthalmology, Department of Ophthalmology, University of Colorado School of Medicine, Denver, CO 2003 – 2004 Fellowship: Vitreoretinal Disease and Surgery, Department of Ophthalmology, University of Colorado School of Medicine, Denver, CO ACADEMIC APPOINTMENTS 2003 – 2004 Instructor, Department of Ophthalmology, University of Colorado School of Medicine, Denver, CO 2004 – 2009 Assistant Professor, Department of Ophthalmology, University of Colorado School of Medicine, Denver, CO 2009 – Associate Professor, Department of Ophthalmology, University of Colorado School of Medicine, Denver, CO ADMINISTRATIVE APPOINTMENTS 2004 – Secretary, Clinical Committee, Department of Ophthalmology, CUSOM 2004 – Chair, Clinical Laboratory Sub-Committee, Dept. of Ophthalmology, CUSOM 2004 – Residency Selection Committee, Department of Ophthalmology, CUSOM 2004 – Clinical Faculty Promotions Committee, Department of Ophthalmology,
    [Show full text]
  • Efficacy of the Quickert Procedure for Involutional En- Tropion : the First Case Series in Asia
    136 ORIGINAL Efficacy of the Quickert procedure for involutional en- tropion : the first case series in Asia Tatsuro Miyamoto1), Hiroshi Eguchi1), Takashi Katome1), Toshihiko Nagasawa1), Yoshinori Mitamura1), Geoffrey Crawford, FRANZCO, FRACS2) 1)Department of Ophthalmology, Institute of Health Biosciences, the University of Tokushima Graduate School, Tokushima, Japan ; and 2)Centre for Ophthalmology and Visual Science, University of Western Australia and the Lions Eye Institute, Western Australia, Australia Abstract : Purpose : To report the efficacy of the Quickert procedure in the first case se- ries of involutional entropion in an elderly Asian population, and to introduce the tech- nique to Asian ophthalmologists including general ophthalmologisits and ophthalmic trainees. Methods : We conducted a retrospective review of 13 consecutive patients un- derwent the Quickert procedure for involutional entropion by occasional eyelid surgeons at Tokushima University Hospital or Mino Tanaka Hospital from September 2003 to April 2010. Demographic data, including gender, age, history of previous eyelid surgery, systemic disease, recurrence of entropion, postoperative complications, and symptoms were analyzed. Results : There were 5 male (38.5%%) and 8 female (61.5%%) subjects with a mean age of 77.8 years. Three patients underwent previous surgery for entropion were included. Entropion was rectified in all patients by a single Quickert procedure, and no recurrence was observed for a maximum of 89 months after the surgery. Although notching of the eyelid margin and mild symblepharon were observed in one patient, no symptoms associated with these complications were reported. Conclusion : The Quickert procedure can be one of the surgical procedures of choice for involutional entropion and should be common surgical approach for occasional eyelid surgeons in Asia as well as in western countries.
    [Show full text]
  • 2019 Spring Vision News
    Vision News Spring 2019 It’s Eureka! for LEI researchers Lions Eye Institute (LEI) researchers won the prestigious UNSW Eureka Prize for Scientific Research, at the Australian Museum Awards ceremony in Sydney on 28 August. The Eureka Prizes are Australia’s most significant awards for scientific excellence, with the Scientific Research award recognising “outstanding curiosity-driven Dr Paulo Martins, Dr Chris Andoniou, Professor scientific research”. Mariapia Degli-Esposti and Peter Fleming The Prize was awarded in recognition of ground-breaking Dr Chris Andoniou and Peter coming back and causing research into improving the Fleming from the LEI, along disease if they are matched to management of one of the with investigators from QIMR the infecting strain of CMV. Berghofer in Brisbane led by most common viral infections “Ultimately, we want to protect Professor Geoff Hill, now at caused by Cytomegalovirus patients against the impacts of the Fred Hutchinson Cancer (CMV), following CMV, which can severely limit Research Center in Seattle. transplantation. positive outcomes in transplant Professor Mariapia Degli- Their work has significant recipients,” Professor Degli- Esposti, Head of Experimental potential to limit the impact Esposti said. “This discovery Immunology at the LEI and of cytomegalovirus infections is the result of a great Head of Experimental and in bone marrow and organ collaboration between viral and Viral Immunology at the transplant recipients, who transplant immunologists who Monash Biomedicine Discovery have highly compromised want to see patients protected Institute, said the research immune systems and are at from the life-threatening impact team was thrilled that their high risk of developing life- of CMV.” threatening cytomegalovirus- work had been recognised More information about the so prominently.
    [Show full text]
  • Activity Report 2009 – 2010
    Activity Report 2009 – 2010 L V Prasad Eye Institute Kallam Anji Reddy Campus L V Prasad Marg, Banjara Hills Hyderabad 500 034, India Tel: 91 40 3061 2345 Fax: 91 40 2354 8271 e-mail: [email protected] L V Prasad Eye Institute Patia, Bhubaneswar 751 024 Orissa, India Tel: 91 0674 3989 2020 Fax: 91 0674 3987 130 e-mail: [email protected] L V Prasad Eye Institute G M R Varalakshmi Campus Door No: 11-113/1 Hanumanthawaka Junction Visakhapatnam 530 040 Andhra Pradesh, India Tel: 91 0891 3989 2020 Fax: 91 0891 398 4444 L V Prasad Eye Institute e-mail: [email protected] Excellence • Equity • Effi ciency Art with vision, for vision Artist-in-residence Sisir Sahana in his workshop on A view of the Art Gallery on Level 6 at Hyderabad LVPEI’s Kallam Anji Reddy campus, Hyderabad creating campus, where several works by Mr Surya Prakash, one of his signature glass sculptures. Inset: A piece from our senior artist-in-residence are on display. his latest collection, entitled “The long climb”. Inset: The hand that wields the paintbrush! L V Prasad Eye Institute Committed to excellence and equity in eye care Activity Report April 2009 – March 2010 Collaborating Centre for Prevention of Blindness L V Prasad Eye Institute, a not-for-profi t charitable organization, is governed by two trusts: Hyderabad Eye Institute and Hyderabad Eye Research Foundation. Donations to Hyderabad Eye Research Foundation are 175% exempt under section 35 (i) (ii) and donations made to Hyderabad Eye Institute are 50% exempt under section 80G of the Income Tax Act.
    [Show full text]
  • Ophthalmology 2018
    Winter 2018–19 UNIVERSITY OF CINCINNATI OPHTHALMOLOGY 2018 Mission: Education 1999 1976 1964 UNIVERSITY OF CINCINNATI Department of OPHTHALMOLOGY Karl C. Golnik, MD, MEd Professor and Chair Hisham H. Arar, MD James J. Augsburger, MD Shana Brafman, OD Chairman’s Update Sandra Brooks, OD David Brounley, MD Greetings! I hope you found our last newsletter’s emphasis on our department’s global activities exciting. Thanks Kelsey Carriere, OD to all of you who provided positive feedback. In this issue, we highlight our Department’s educational history by Mark Cepela, MD Fred Chu, MD featuring our alumni and their current activities. In 2008 we increased the size John S. Cohen, MD of the residency from three to four residents per year. Fifteen years ago, most of Anne L. Corn, EdD Zelia M. Correa, MD, PhD our graduates went into private practice comprehensive ophthalmology, but Michael E. Daun, MD Eniolami Dosunmu, MD this has almost completely reversed with the majority now doing subspecialty William J. Faulkner, MD fellowships. In collaboration with the Cincinnati Eye Institute and Cincinnati Robert E. Foster, MD W. Michael Gaynier, DO Children’s Hospital Medical Center, we now offer fellowships in retina (two Gian Paolo Giuliari, MD Robert Goulet, MD per year), glaucoma, cornea and external disease, pediatric ophthalmology, Michael E. Gray, MD oculoplastic surgery, ocular oncology and neuro-ophthalmology. The growth Linda J. Greff, MD Fumika Hamada, PhD of our fellowship programs has enriched the resident experience and keeps our Daniel Hammer, MD Michael Hater, MD subspecialists at the forefront of knowledge and training. Our next newsletter Ginger Henson, MD will highlight philanthropy and how you can strengthen our department.
    [Show full text]
  • Therapeutic Strategies for Large Protein Coding Genes in Usher Syndrome Virtual Meeting Thursday-Friday May 13-14, 2021
    Therapeutic Strategies for Large Protein Coding Genes in Usher Syndrome Virtual Meeting Thursday-Friday May 13-14, 2021 Day 1: Thursday May 13, 2021 Session 1: Genetic Interventions for Protocadherin 15 Related Disorders (Usher 1F) 8:15 Elliot Chaikof introduces Alex Hewitt Alex Hewitt, MD, PhD is a Professor of Ophthalmology at the Menzies Institute for Medical Research at the University of Tasmania in Australia. He received his MD from the University of Tasmania, his PhD from the Flinders University of South Australia and completed a residency in ophthalmology at the Royal Victorian Eye and Ear Hospital in Melbourne after which he was a Novartis Research Fellow at the Lions Eye Institute in Perth Australia. Prof. Hewitt’s research interests lie in the genetics of a wide range of ocular disorders, including glaucoma and retinitis pigmentosa, as well as in the application of stem cell-based models of eye disease and the development of genetic therapies. 8:45 Alex Hewitt introduces Livia Carvalho Livia Carvalho, PhD leads the Retinal and Genomic Therapies Research Group at the Lions Eye Institute in Perth Australia. After completing a BSc in Biological Sciences from the University of Brasilia, she pursued further studies in the UK, completing a Masters in Neuroscience and a PhD in Genetics at the University College London Institute of Ophthalmology. Following additional postdoctoral studies in the areas of inherited degenerative eye diseases and ocular gene therapy at UCL and Harvard, she joined the Lions Eye Institute. Prof. Carvalho’s research program focuses on the development of therapies for inherited vision loss, including Usher Syndrome, using AAV technologies, as well as investigating basic cellular and molecular mechanisms responsible for vision loss.
    [Show full text]
  • Dry Age-Related Macular Degeneration (AMD) Is One of the Most Common Causes of Irreversible Blindness
    Research on Dry AMD at the Lions Eye Institute Dry age-related macular degeneration (AMD) is one of the most common causes of irreversible blindness. Unlike the wet form of AMD, the dry form of AMD can progress very slowly and it can impair reading ability for many years before it is detected. Research at Lions Eye Institute is being conducted into exploring the risk factors for dry AMD, characterising different types of dry AMD, clinical trials of novel drug treatment and the potential of cell replacement therapy. Macula is a specialised area of the light sensing retina that serves central vision, allowing us to read, see people’s faces and drive a car. As dry AMD develops, many people will require greater contrast in the text they read and brighter light to see objects clearly at night. Some will notice distortion and blur patches of vision in the centre causing “letters on the page to jump around”. One eye is often affected more severely than the other and hence many people will ignore these symptoms of early dry AMD until the better seeing-eye is losing sight. Several risk factors for development of dry AMD have been proposed including smoking and family history. Research has shown specific formulation of vitamins and minerals may be beneficial in retarding progression of high risk early AMD to late stage AMD. However, use of these supplements should be discussed with a retinal specialist who can distinguish high risk early AMD from other macular diseases such as pattern dystrophy or central serous retinopathy that can often be confused with the common type of AMD.
    [Show full text]
  • Image of the Month the Human Choroid, Reconstructed in 3D
    APRIL 2016 # 29 Image of the Month Upfront Profession Sitting Down With The human choroid, Growing your own Benchmarking your practice Amar Agarwal, Chairman of reconstructed in 3D crystalline lens against your peers Dr Agarwal’s Eye Hospital 03 08 – 10 60 – 64 66 – 67 www.theophthalmologist.com DUAL-SEGMENT PUMP TECHNOLOGY + Precise fluidics + Pulsatile-free + Quick vacuum rise + Versatile performance PERFORMANCE IN EVERY DETAIL Superior chamber stability through superior engineering.†,1,2 That’s the Centurion® Effect. Active Fluidics™ Technology • Helps to Maintain Chamber Stability: Detects and compensates to help provide superior chamber stability3 compared to INFINITI®4 • Less Surge: Less surge at any tested vacuum level3,5 • More Consistent IOP4 : Up to 80% less surge area3,5 Contact your Alcon representative to schedule a demonstration and experience the Centurion® Effect for yourself. †As compared to the INFINITI® Vision System, bottle gravity system. 1. Lorente R, Fanney D, Injev V, Sharif-Kashani P. Quantification of occlusion break surge in peristaltic-based phacoemulsification systems. ASCRS-ASOA Symposium and Congress; April 25-29, 2014; Boston, USA.2. Nicoli M, Miller K, Dimalanta R, Loke D; Jules Stein Eye Institute, UCLA. IOP Stability Measurement and Comparison Between Gravity-Fed and Actively Controlled Phacoemulsification Systems. 2014. 3. Sharif-Kashani P, Fanney D, Injev V. Comparison of occlusion break responses and vacuum rise times of phacoemulsification systems. BMC Ophthalmol. 2014;14:96. 4. Nicoli CM, Dimalanta R, Miller K. Experimental anterior chamber maintenance in active versus passive phacoemulsification fluidics systems. J Cataract Refract Surg. 2016;42(1):157-162. 5. Alcon data on file.
    [Show full text]
  • Jules Stein Eye Institute
    Annual Report 2009–2010 Jules Stein Eye Institute Looking Towards the Future The emblem of the Jules Stein Eye Institute is adapted from the schematic eye used by Sir Isaac Newton in his classic treatise on human vision—“Opticks”— published in 1704. The horizontal lines extending from the surface of the eye represent Newton’s concept of the major colors that are in the spectrum of light. Jules Stein Eye Institute Annual Report 2009–2010 director Bartly J. Mondino, MD faculty advisor Debora B. Farber, PhD, DPhhc managing editor Gloria P. Jurisic editors Irene Y. Chen Sara V. Nguyen photography Reed Hutchinson PhotoGraphics J. Charles Martin design Robin Weisz/Graphic Design production The Oak Company printing Marina Graphic Center ©2010, by the Regents of the University of California. All rights reserved. This report covers the period July 1, 2009, through June 30, 2010. Requests for additional copies of the publication Jules Stein Eye Institute Annual Report 2009–2010 may be sent to: Office of the Managing Editor Jules Stein Eye Institute 100 Stein Plaza, UCLA Box 957000 Los Angeles, California 90095-7000 Phone: (310) 206-7178 For more information on the Institute, see our website: www.jsei.org View the Annual Report online at: jsei.org/annual_report.htm Printed on recycled paper using soy-based inks Contents Introduction Jules Stein iii Doris Stein iii Board of Trustees iv Executive Committee v In Memoriam—Arthur L. Rosenbaum, MD vi Highlights 1 Honors 3 Research 7 Education 12 Philanthropy 16 Thank You 18 Endowed Professorships, Fellowships, and Other Funds 20 Community Outreach 23 Faculty 25 Programs 75 Patient Care Services 76 Research and Treatment Centers 77 Clinical Laboratories 81 Training Programs 83 Appendices 89 Volunteer and Consulting Faculty 90 Residents and Fellows 92 Educational Offerings 93 Research Contracts and Grants 95 Clinical Research Studies 104 Publications of the Full-Time Faculty 110 Giving Opportunities 118 The legacy of Dr.
    [Show full text]
  • Curriculum Vitae
    CURRICULUM VITAE Tal Joshua Rubinstein, MD August 27, 2018 PERSONAL DATA: Work Home Ophthalmic Plastic Surgery 17 Chapel Rd Apt 301 Lions Eye Institute, Suite 302 Albany, NY 12210 1220 New Scotland Rd. Slingerlands (Albany), NY 12159 DOB: November 23, 1983 Phone: 518-533-6540 Citizenship: USA Fax: 518-533-6542 EDUCATION: 2007-2011 Doctor of Medicine, Distinction in Research, summa cum laude Saint Louis University School of Medicine St. Louis, MO 2002-2006 Bachelor of Science University of Wisconsin – Madison Madison, WI Double major in Psychology (with honors) and Zoology POST-GRADUATE TRAINING: 8/2017-8/2018 Fellowship in ophthalmic plastic surgery, Moorfields Eye Hospital, UK 7/2015 – 7/2017 Fellowship American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) Fellow under Bryan Sires MD, PHD, FACS and Eric Cole MD 7/2012 – 6/2015 Ophthalmology Residency Cleveland Clinic Foundation, Cole Eye Institute Cleveland, OH 7/2011-6/2012 Internal Medicine Internship MetroHealth Medical Center Cleveland, OH Internal Medicine FACULTY POSITIONS HELD: 2016-2017 Clinical Instructor, Department of Ophthalmology University of Washington Seattle, WA Curriculum Vitae Tal J. Rubinstein, MD Page 2 HOSPITAL POSITIONS HELD: 2016-2017 Active medical staff Harborview Medical Center Seattle, WA 2016-2017 Active medical staff University of Washington Seattle, WA 2016-2017 Active medical staff VA Puget Sound Healthcare Center Seattle, WA 2015-2017 Active medical staff Department of Ophthalmology Overlake Hospital Bellevue, WA HONORS AND AWARDS: 2017 Doctor of the Month, April Emergency Physicians at Overlake 2015 Best Grand Rounds Quiz Score Cole Eye Institute 2011 Student Research Forum Award Saint Louis University School of Medicine 2011 Missouri State Saint Louis University School of Medicine Medical Association Award 2011 Merck Book Award Saint Louis University School of Medicine 2011 Henry M.
    [Show full text]